If you were able to make more money at a company you found less desirable than your current one, would it be worth it? Conversely, would you move to a better company and a better role and accept less pay?…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Japan Approves Padcev, Entresto’s Hypertension Use, Lilly’s RET Inhibitor and More
September 28, 2021
-
REGULATORY Japan Approves GSK’s COVID-19 Antibody Drug, 2nd Treatment for Mild Cases
September 28, 2021
-
ORGANIZATION Chuikyo Payer Rep Wants to Cut into Cost-Based Method, Adjustment Rate, Off-Year Revision in FY2022 Reform, Eyes Special Rules for Aducanumab
September 27, 2021
-
BUSINESS Startup Headed by Ex-Biogen Japan Chief Working to Develop New Alzheimer’s Drugs Using Photocatalysts
September 27, 2021
-
REGULATORY One-Month Business Suspension Order Likely for Choseido over Generic Recalls
September 24, 2021
-
BUSINESS Shionogi to Begin PII/III Study for Oral COVID-19 Drug on Sept. 27: President
September 24, 2021
-
BUSINESS Shionogi Gets New Oral COVID-19 Drug into Clinic in Less than 1 Year, Now Gearing Up for PII/III
September 24, 2021
-
ORGANIZATION JPMA Chief Opposes Macroeconomic Indexing, Says Drugs Should Drive Economic Growth
September 22, 2021
-
REGULATORY GSK/Vir’s COVID-19 Drug Up for MHLW Panel Review on Sept. 27
September 22, 2021
-
BUSINESS New Heart Failure Drugs Jostling with Different Modes of Action, Offering Variety of Options
September 21, 2021
-
REGULATORY All 4 Contenders in LDP Leadership Race Vow to Expand COVID-19 Measures
September 21, 2021
-
REGULATORY Japan to Start Discussions in October on Reinstating HPV Vaccine Recommendation
September 21, 2021
-
REGULATORY Japan to Offer COVID-19 Booster Shots, Targets to Be Discussed Later
September 21, 2021
-
BUSINESS Sumitomo Dainippon Expects Twymeeg’s Initial Uptake in Combo, but Eyes 1st Line Monotherapy Use Too
September 17, 2021
-
BUSINESS White Matter Found in COVID-19 Vaccine Vials Not Contaminant: Pfizer
September 16, 2021
-
REGULATORY Tainted Moderna Jabs Run Afoul of PMD Law: Minister
September 16, 2021
-
REGULATORY Japan Eyes Legal System to Ensure Generic Supplies in New Industry Vision, Key Official Says It’s Difficult with Companies’ Own Efforts Alone
September 15, 2021
-
REGULATORY Japan Unveils New Pharma Industry Vision, 1st Update in 8 Years
September 14, 2021
-
BUSINESS Chugai Lifts Shipment Curbs for Edirol, Easing Active Vitamin D3 Shortages
September 13, 2021
-
REGULATORY Causal Link between Deaths and Recalled Batch of Moderna Jab “Indeterminable”
September 13, 2021
ページ
Over two years after the rollout of the cost-effectiveness assessment (CEA) scheme in April 2019, discussions on its system reform are set to go into full swing at a key reimbursement policy council known as Chuikyo. Both payer and healthcare…
The average ratio of female employees at managerial posts stood at just 12.5% at pharmaceutical companies operating in Japan, a Jiho survey revealed. While foreign drug makers had an average 25.0%, the ratio came to as low as 9.8% for…
Biogen’s controversial Alzheimer’s drug aducanumab was filed for Japanese regulatory approval in December. If approved, it will be the first…
Japan’s key reimbursement policy panel on December 20 approved an outline of its FY2020 drug pricing reform next April, with…
Japan will go ahead with the introduction of a cost-effectiveness assessment (CEA) scheme for drugs and medical devices in April…